MK
Therapeutic Areas
Resoundant Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Liver MRE for Fibrosis Staging | Liver Fibrosis (MASLD, MASH, Hepatitis) | Approved |
| MRE as a Biomarker in Clinical Trials | MASH (as a surrogate endpoint) | Biomarker Qualification |
| MRE for Tumor Characterization | Oncology (Brain, Breast, Prostate Tumors) | Pre-clinical/Research |